Atazanavir
Active substance: atazanavir
CAPSULE · ATAZANAVIR SULFATE 200 mg/1
United StatesActive
Marketing holder: Laurus Labs Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- ATAZANAVIR SULFATE · 200 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 38 |
|
| EU 4 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3042-7378-8f34-a0d2372a5f5b,01a120c3-3d0c-754c-ac7d-a9f707148ce9,01a120c3-4583-76d3-ad5b-c430d819769c,01a120c3-6202-7639-929a-4bf0a7e57306,01a120c3-8a48-7c4c-aba8-616f346657b4;count=28 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4cc7-7d04-a2b1-7b28ed7689cf,01a1208c-501e-7145-81f8-1eb17c9a183a,01a1208d-00b1-770b-beea-b3e5ddbae5cf,01a1208d-0129-7250-93e9-1a6580a4d98a,01a1208e-0e8b-7e7b-a0a7-7bfbad15868a;count=16 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 42385-921
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 42385-921 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 42385-921 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 42385-921 · Verified 2026-10-09 · open in source